Citation Nr: A25066193 Decision Date: 08/05/25 Archive Date: 08/05/25 DOCKET NO. 250103-498429 DATE: August 5, 2025 REMANDED 1. Service connection for pancreatic cancer. 2. Service connection for the cause of death. ? REASONS FOR REMAND The Veteran served on active duty from February 1964 to February 1967. The Veteran died in August 2022. The appellant is his surviving spouse. The case is on appeal from a May 2024 rating decision. In the January 2025 notice of disagreement (NOD) (VA Form 10182, Decision Review Request: Board Appeal), the Veteran elected the Hearing docket. Therefore, the Board may only consider the evidence of record at the time of the May 2024 RO decision on appeal, as well as any evidence submitted by the Veteran, or attorney representative, at the hearing or within 90 days following the hearing. See 38 C.F.R. § 20.302(a). If evidence was submitted either (1) during the period after the RO issued the decision on appeal and prior to the Board hearing, or (2) more than 90 days following the hearing, the Board did not consider it in its decision. See 38 C.F.R.§§ 20.300, 20.302(a), 20.801. However, because the Board is remanding the claims in this appeal, any evidence the Board could not consider will be considered by the RO in the adjudication of those claims. See 38 C.F.R. § 103(c)(2)(ii). In April 2025, the Veteran testified at a Board hearing. The Board notes that in a May 2025 correspondence, the appellant waived any remaining time under the Hearing docket 1. Service connection for pancreatic cancer. 2. Service connection for the cause of death. The appellant contends that he had pancreatic cancer that was incurred in or caused by service, to include exposure to radiation. Prior to this death, in a March 2022 correspondence, the Veteran had reported that he was not exposed to radiation from detonation of a nuclear device. However, he reported exposure to radiation in 1964, 1965, and 1966 as part of his job as a Forward Assembly Specialist in the 529th Engineer Platoon, an Atomic Demolition Munitions unit. He had reported part of his duties included assembling "mock" weapons and visiting several times a year sites in Germany that stored weapons. Also, he had reported that he was required to wear "radiation badges" during the site visits. Furthermore, he reported that he was unable to provide specifics on dates, times, and location because it was all "classified NATO Top Secret" at the time. The Veteran's service personnel records (SPRs) show that he was a combat engineer and received atomic demolition training. Also, he was stationed in Darmstadt, Germany. His service treatment records (STRs) do not show reports of pancreatic cancer or related symptoms. The Veteran's post-service VA treatment records show that he was diagnosed with pancreatic cancer in November 2021. In March 2022, the Veteran submitted 3 positive nexus opinions. While Toxic Exposure Risk Activity (TERA) memorandum is of record, which concedes exposure to ionizing radiation, an Individual Longitudinal Exposure Record (ILER) or similar record, is not. The May 2024 rating decision has already made favorable findings that the Veteran was exposed to radiation during active service and is diagnosed with prostate cancer. As noted above, the Veteran had participated in a TERA during service due to having been training in atomic demolitions and having had duties that involved being exposed to radiation. In addition, his VA treatment records show a diagnosis of prostate cancer. Specific to the Veteran's assertion regarding exposure to ionizing radiation, the Veteran is not a radiation-exposed veteran as defined in 38 C.F.R. § 3.309(d). However, as the Veteran was exposed to ionizing radiation and developed a radiogenic disease, his claim was referred to the Under Secretary for Benefits pursuant to 38 C.F.R. § 3.311(b). In an April 2022 opinion, the Director of Compensation Service concluded that the Veteran's exposure to less than 10 rems of ionizing radiation during service did not cause his pancreatic cancer, as doses less than 10 rems did not statistically increase risk of radiation diseases. However, the Director failed to reconcile this conclusion with positive evidence from the National Academies of Sciences, Engineering, and Medicine, that there is an excess risk of approximately 1 percent in addition to the natural rate of fatal cancer in the general population of about 20 percent in those instantaneously exposed to 10 rems of ionizing radiation. The Board acknowledges the Director's assertion that a discussion of each of the factors listed in 38 C.F.R. § 3.111(e) is not required. See Stone v. Gober, 14 Vet. App. 116 (2000). However, because there is an excess risk of approximately 1 percent of fatal cancer in those exposed to certain levels of ionizing radiation, the Board finds that a discussion of the factors is necessary, including the relative sensitivity of the involved tissue to the induction of the specific pathology by ionizing radiation Also, the director indicated that a referral for an advisory medical opinion from the Under Secretary for Health is unnecessary. The Director further concluded that, based on a complete review of the Veteran's records, there is no reasonable possibility that the Veteran's pancreatic cancer is the result of exposure to ionizing radiation during service. In August 2022, a death certificate was submitted stating that the Veteran's cause of death was pancreatic cancer. The Board finds that the claim must be remanded to correct a duty to assist error that occurred prior to the rating decision on appeal. Specifically, the RO did not obtain a medical opinion addressing the etiology of the Veteran's pancreatic cancer. Particularly, as mentioned, above the advisory opinion failed to reconcile positive evidence in the referenced articles with the Veteran's pancreatic cancer conditions and radiation exposure. Also, prostate cancer is under the list of diseases presumed to be due to exposure to ionizing radiation. See 38 C.F.R. § 3.311(b)(2). While an opinion from the Director, Compensation Service, was obtained in relation to the claim under the procedures set out in 38 C.F.R. § 3.311. However, this opinion is not a medical opinion. Regardless, a TERA medical opinion is still necessary under the PACT Act. Because the Board is unable to grant this claim at this time, and because the requirements to obtain a medical opinion compliant with 38 U.S.C. § 1168 are met, but such opinion has not yet been obtained. As such a remand is warranted to correct deficiencies stated above. As to the cause of death claim, the premise is the same as claim of service connection for prostate cancer. Thus, it will also be remanded. The claims are REMANDED for the following action: 1. Verify the Veteran's claimed toxic exposures and identify, to the extent possible, including as necessary, completing an Individual Longitudinal Exposure Record (ILER) or similar record, if warranted. 2. Thereafter, obtain an opinion from an appropriate clinician regarding the Veteran's pancreatic cancer. The examiner must review the claims file. The examiner is asked to provide a response to the following: State whether the Veteran's pancreatic cancer at least as likely as not related to service, including in-service exposure to ionizing radiation while serving in Germany for 37 months from 1964 to 1966. Also, the examiner must consider: The total potential exposure through all applicable deployments; and the synergistic, combined effect of all toxic exposure risk activities of the Veteran. The examiner should reconcile the positive evidence referenced in the April 2023 advisory opinion with the negative opinions of record. Also, the examiner should review and address the Veteran's and appellant's lay reports, SPRs, VA treatment, private treatment records, and opinions of record. RYAN T. KESSEL Veterans Law Judge Board of Veterans' Appeals Attorney for the Board Nevarez-myrick, Nancy The Board's decision in this case is binding only with respect to the instant matter decided. This decision is not precedential and does not establish VA policies or interpretations of general applicability. 38 C.F.R. § 20.1303.